An Adept and Amusing Analysis of Science

Science in Action. Bruno Latour. Harvard University Press, Cambridge, MA, 1987. 274 pp. $25. Sacrebleu! This is science? Forget those preconceptions now comfortably a part of how you see science and the sociology of it, or how you see nature and society. Here instead we have sketches of Janus: on the left a graybeard tells us that "Nature is the cause that allowed controversies to be settled"; on the right, a more youthful half-face tells us that "Nature will be the consequence of settlement." A

Written byThomas Gieryn
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For Bruno Latour, a Parisian anthropologist at the Ecole National Supérieure des Mines and not yet a graybeard, everywhere. Forget that science is a body of factual knowledge about reality, and forget too a sociology (or history) of science hung up on whether scientific knowledge is determined by nature, or by society, or by some of each. That is science out of action. Putting science back in action means to consider facts before they are facts and machines before they are machines, focusing on the controversies, the persuasions, the mustering of support, the gathering of resources, the denunciation of nay-sayers that precede the finished and usable fact or machine.

Latour makes us see science (a softish and loosely-tied network of alliances linking people in laboratories to consumers or politicians in a seamless web of mutual interests) before it becomes Science (disinterested researchers pursuing hard truth in autonomous and expensive universities). ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies